Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
08/05/20166:00AMGlobeNewswire Inc.Summit Therapeutics to Present at Canaccord Genuity Growth ConferenceNASDAQ:SMMTSummit Therapeutics Inc
07/18/20163:37PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
06/24/20163:24PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
06/20/201611:30AMGlobeNewswire Inc.Summit’s Ridinilazole Preserves Microbiome During Treatment of C. Difficile InfectionNASDAQ:SMMTSummit Therapeutics Inc
06/17/20163:23PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
06/17/20166:00AMGlobeNewswire Inc.First Patient Enrolled in Summit’s PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Boys With DMDNASDAQ:SMMTSummit Therapeutics Inc
06/16/20166:00AMGlobeNewswire Inc.Summit Therapeutics to Present at JMP Securities Life Sciences ConferenceNASDAQ:SMMTSummit Therapeutics Inc
06/08/20166:00AMGlobeNewswire Inc.Summit Therapeutics to Host Utrophin R&D Day 15 June 2016NASDAQ:SMMTSummit Therapeutics Inc
06/06/20165:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SMMTSummit Therapeutics Inc
06/02/20163:36PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
06/02/20166:00AMGlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the First Quarter Ended 30 April 2016 and Operational ProgressNASDAQ:SMMTSummit Therapeutics Inc
05/31/20166:00AMGlobeNewswire Inc.Summit Therapeutics to Report Financial Results for the First Quarter Ended 30 April 2016 on 2 June 2016NASDAQ:SMMTSummit Therapeutics Inc
05/26/20163:17PMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:SMMTSummit Therapeutics Inc
05/25/20168:44AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:SMMTSummit Therapeutics Inc
05/23/20166:00AMGlobeNewswire Inc.Summit to Present Phase 2 CoDIFy Trial Data Highlighting Ridinilazole's Preservation of the Microbiome in CDI Patients at ASM...NASDAQ:SMMTSummit Therapeutics Inc
05/12/20165:06AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:SMMTSummit Therapeutics Inc
05/12/20165:06AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:SMMTSummit Therapeutics Inc
05/10/20164:55PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
05/10/20166:00AMGlobeNewswire Inc.Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2016NASDAQ:SMMTSummit Therapeutics Inc
05/06/20166:00AMGlobeNewswire Inc.Summit Therapeutics Provides Notice of Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2016NASDAQ:SMMTSummit Therapeutics Inc
04/29/20166:11AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
04/28/201610:46AMGlobeNewswire Inc.Summit’s IND Cleared by FDA Allowing Expansion of PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid (SMT C1100), Into the...NASDAQ:SMMTSummit Therapeutics Inc
04/28/20166:00AMGlobeNewswire Inc.Summit Announces Further US Patent Granted for CDI Antibiotic RidinilazoleNASDAQ:SMMTSummit Therapeutics Inc
04/26/20163:33PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
04/12/20164:12PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
04/11/20166:00AMGlobeNewswire Inc.Positive Results From Summit's Phase 2 CoDIFy Trial Highlight Potential of Ridinilazole in the Treatment of C. difficile Infe...NASDAQ:SMMTSummit Therapeutics Inc
04/06/20166:00AMGlobeNewswire Inc.Summit Therapeutics to Present at 15th Annual Needham Healthcare ConferenceNASDAQ:SMMTSummit Therapeutics Inc
03/30/20163:54PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
03/30/20166:00AMGlobeNewswire Inc.Summit Reports Positive Interim Data From Ongoing Phase 1 Clinical Trial Testing a New Formulation of SMT C1100 in Patients W...NASDAQ:SMMTSummit Therapeutics Inc
03/29/20168:25AMGlobeNewswire Inc.Summit to Present Additional Data From Phase 2 CoDIFy Trial Showing Ridinilazole’s Statistical Superiority Over Vancomycin ...NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT

Your Recent History

Delayed Upgrade Clock